In multiple models of CD19 escape in primary ALL, they showed that trivalent CAR T cells mitigated CD19 negative relapse, producing IFN-γ/TNF-α and killing CD19-negative primary ALL, while CD19 CAR T cells remained ineffective. This evidence concerns the gene TNF and acute lymphoblastic leukemia.